Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand access soon.

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across Ozempic (semaglutide). And that means you might have come across Ozempic ...

Curious about Ozempic benefits? Here’s who could benefit from using these medications—and why they’re not just for weight ...

The high monthly costs of GLP-1s — ranging from $1,000 to $1,500 — are placing considerable financial pressure on healthcare ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...

There's a nasty aroma coming from Harvey Jones's Self-Invested Personal Pension. These five UK shares are to blame. Should he ...

Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...